Chauhan, Anil Kumar
- University of Iowa · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #7,836
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$1.2M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#7,836
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Chauhan, Anil Kumar as a PI. Multi-PI records show the full award amount for context.
- 5R35HL139926-06R35Contact PITargeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammationUniversity of Iowa · Internal Medicine (NIH department code)$758.8Kaward amount
- 5R01NS109910-05R01Contact PINovel therpeautic interventions to treat ischemic strokeUniversity of Iowa · Internal Medicine (NIH department code)$468.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Chauhan, Anil Kumar as a PI.
FY2023 award administered by University of Iowa (IA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardUniversity of Iowa
- 2014$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #9714
- 2016$2M Cumulative Funding
- 2016R01 Grant Holder
- 2019$5M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #2548